HR 3810 · 118th Congress · Health

Drug Origin Transparency Act of 2023

Introduced 2023-06-05· Sponsored by Rep. Eshoo, Anna G. [D-CA-16]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2023-06-09)

Plain Language Summary

[AI summary unavailable — showing source text] Drug Origin Transparency Act of 2023  This bill requires drug manufacturers to report on the suppliers of ingredients used in their products. Specifically, drug manufacturers must report information relating to the supply chain of their products, including the suppliers of active ingredients and the amount of drugs that are manufactured using those ingredients. Drug manufacturers must also include information about the manufacturers of ingredients on the labels of their products.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (4)

4 Democrats